GENOA VENTURES
About Portfolio Careers Team Strategic Partners News & Events Contact
AboutPortfolioCareersTeamStrategic PartnersNews & EventsContact
  GENOA VENTURES
A Conversation with a Nobel Laureate - Dr. Carolyn Bertozzi & Dr. Jenny Rooke
A Conversation with a Nobel Laureate - Dr. Carolyn Bertozzi & Dr. Jenny Rooke
Andrea VuturoJanuary 17, 2024
Genoa Ventures Named to Inc.’s 2023 List of Founder-Friendly Investors for Third Year in a Row
Genoa Ventures Named to Inc.’s 2023 List of Founder-Friendly Investors for Third Year in a Row
Andrea VuturoDecember 1, 2023
Ionpath Launches MIBIplus and MIBIsight, A New Service Offering and User-Friendly Bioinformatics Tools
Ionpath Launches MIBIplus and MIBIsight, A New Service Offering and User-Friendly Bioinformatics Tools
Andrea VuturoNovember 1, 2023
Aqtual Raises $16 Million in Series A Fund
Aqtual Raises $16 Million in Series A Fund
Andrea VuturoNovember 1, 2023
Trends We are Watching in AgriFood Industry in 2023 and Beyond
Trends We are Watching in AgriFood Industry in 2023 and Beyond
Andrea VuturoMay 19, 2023
10 Women Investors Betting Big On Synthetic Biology
10 Women Investors Betting Big On Synthetic Biology
Andrea VuturoMay 10, 2023
How Early-Stage Investors Can Prepare for an Uncertain Outlook
How Early-Stage Investors Can Prepare for an Uncertain Outlook

Jenny Rooke PhD, shares with Fortune how early-stage investors can best prepare for an uncertain future.

Read More
Genoa NewsJenny RookeMarch 14, 2023
BrightSpec Announces $18.4 Million Financing Round
BrightSpec Announces $18.4 Million Financing Round

BrightSpec, Inc., a life science tools company commercializing Molecular Rotational Resonance (MRR) spectroscopy, announced today the closing of an $18.4 million Series C financing round, led by Genoa Ventures and Arboretum Ventures.

Read More
Genoa NewsJenny RookeDecember 15, 2022
Genoa Ventures Again Named to Inc.’s Annual List of Founder-Friendly Investors - 2022
Genoa Ventures Again Named to Inc.’s Annual List of Founder-Friendly Investors - 2022
Genoa NewsAndrea VuturoOctober 7, 2022
 Jenny Rooke featured in Vator News
Jenny Rooke featured in Vator News
Genoa NewsGuest UserSeptember 12, 2022
Bond Pet Food raises Series A to "Brew Meat"
Bond Pet Food raises Series A to "Brew Meat"
Genoa NewsGuest UserSeptember 12, 2022
Genoa Ventures Closes Second Fund, at $84M
Genoa Ventures Closes Second Fund, at $84M
Genoa NewsAndrea VuturoAugust 3, 2022
Jenny Rooke's Journey is an Inspiration for New Managers
Jenny Rooke's Journey is an Inspiration for New Managers
Genoa NewsAndrea VuturoAugust 3, 2022
Life Sciences Investor Genoa Ventures Raises $84 Million Second Fund
Life Sciences Investor Genoa Ventures Raises $84 Million Second Fund
Genoa NewsAndrea VuturoAugust 3, 2022
VC raises $84M fund to back agbio, foodbio and other non-drug biotechs
VC raises $84M fund to back agbio, foodbio and other non-drug biotechs
Genoa NewsAndrea VuturoAugust 3, 2022
Genoa Targets Nexus of Biology and Technology with New Fund
Genoa Targets Nexus of Biology and Technology with New Fund
Genoa NewsAndrea VuturoAugust 3, 2022
Genoa Ventures Announces Second Fund to Expand Investing in the Convergence of Biology and Technology
Genoa Ventures Announces Second Fund to Expand Investing in the Convergence of Biology and Technology
Genoa NewsAndrea VuturoAugust 2, 2022
New roles in Genoa Ventures as the firm continues to grow.
New roles in Genoa Ventures as the firm continues to grow.
Genoa NewsAndrea VuturoMay 16, 2022
Jenny Rooke & the VC Climate
Jenny Rooke & the VC Climate
Genoa NewsAndrea VuturoMay 12, 2022
Meiogenix Announces $13 Million series A financing round
Meiogenix Announces $13 Million series A financing round
Portfolio NewsAndrea VuturoMay 4, 2022
Newer Older
 
San Francisco, CA
jenny@genoavc.com
Hours

©2020-2025 Genoa Ventures. All rights reserved.